Medical

The Medicines and Healthcare products Regulatory Agency announced on 11 February 2026 that new restrictions now apply to the Chikungunya...

Public sector energy costs remain a continuing pressure on health, defence and custodial estates across the UK, with hospitals and...

Rare cancers account for a substantial share of cancer diagnoses across the UK and Europe, with many patients facing limited...

Medical training capacity and workforce planning remain central to how the NHS manages long-term staffing levels across hospitals and community...

Across partner countries, medicines regulators are working to align approval processes and share assessments to improve patient access to authorised...

Across England, access to cancer diagnosis, specialist treatment, and detection technology continues to vary by region, with workforce shortages and...

The Medicines and Healthcare products Regulatory Agency confirmed on 17 January 2026 that paracetamol remains the recommended first-choice medicine for...

Medicines used to treat pain, anxiety, and insomnia are widely prescribed across the UK, with millions of patients relying on...

The UK medicines regulator continues to expand treatment options for rare conditions through regulated approvals supported by clinical evidence and...

The government has announced reforms to NHS dentistry in England intended to make urgent dental appointments easier to access and...